Results

Total Results: over 10,000 records

Showing results for "drugs".

  1. effectivehealthcare.ahrq.gov/sites/default/files/related_files/episodic-migraine-surveillance-report-3.pdf
    August 01, 2022 - Results from included studies: KQ 2, nonsteroidal anti-inflammatory drugs ............ … Biohaven Pharmaceuticals I. … Biohaven Pharmaceuticals I. … Rimegepant 75 mg is more effective for migraine than nonsteroidal anti- inflammatory drugs: post hoc … CNS Drugs. 2020 Oct;34(10):1015-24. doi: 10.1007/s40263-020-00753-1. PMID: 32857291.
  2. www.ahrq.gov/sites/default/files/2024-01/sirio-report.pdf
    January 01, 2024 - Final Progress Report: Enhanced Patient Safety Intervention to Optimize Medical (EPITOME) Enhanced Patient Safety Intervention to Optimize Medical (EPITOME) Carl A. Sirio, MD Principal Investigator Team Members: Robert Weber, RPh, MS, Co-Investigator Wishwa Kapoor, MD, Co-Investigator Mark Roberts, MD, MRP, Co-…
  3. effectivehealthcare.ahrq.gov/sites/default/files/pdf/diabetes-foot-ulcer-amputation-economics_research.pdf
    January 01, 2011 - Economic burden of diabetic foot ulcers and amputations Data Points #3Diabetic Foot Ulcers Beneficiaries with a diabetic foot ulcer are seen by their outpatient health care provider about 14 times per year and are hospitalized about 1.5 times per year. The cost of care for these beneficiaries is substantial, at…
  4. digital.ahrq.gov/sites/default/files/docs/citation/enhancedmedhistories_102611comp.pdf
    October 01, 2011 - Reminder rates for elderly patients taking at least two drugs from the list of “Drugs to Avoid in … But as may be seen from Table 20 and 21, drugs from the HEDIS list of “Drugs to Avoid in the Elderly … Reminder rates for elderly patients taking at least two drugs from the list of “Drugs to Avoid in the … most frequent Drugs to Avoid in the Elderly. … Drugs To Be Avoided in the Elderly Category 5.
  5. effectivehealthcare.ahrq.gov/sites/default/files/related_files/hepatitis-c-screening_disposition-comments.pdf
    November 27, 2012 - that HCV treatment can have an impact on incidence rates of HCV infection among people who inject drugs … understood populations with higher prevalence of HCV infection, such as individuals who report injecting drugs … Studies conducted before these drugs became available will therefore have limited applicability for
  6. Psn-Pdf (pdf file)

    psnet.ahrq.gov/node/43824/psn-pdf
    January 21, 2015 - Impact of a warning CPOE system on the inappropriate pill splitting of prescribed medications in outpatients. January 21, 2015 Hsu C-C, Chou C-Y, Chou C-L, et al. Impact of a warning CPOE system on the inappropriate pill splitting of prescribed medications in outpatients. PLoS One. 2014;9(12):e114359. doi:10.1371/j…
  7. Psn-Pdf (pdf file)

    psnet.ahrq.gov/node/41027/psn-pdf
    September 01, 2016 - Clinical decision support systems could be modified to reduce 'alert fatigue' while still minimizing the risk of litigation. September 1, 2016 Kesselheim AS, Cresswell K, Phansalkar S, et al. Clinical decision support systems could be modified to reduce 'alert fatigue' while still minimizing the risk of litigation…
  8. Psn-Pdf (pdf file)

    psnet.ahrq.gov/node/46956/psn-pdf
    January 23, 2019 - Impact of a national QI programme on reducing electronic health record notifications to clinicians. January 23, 2019 Shah T, Patel-Teague S, Kroupa L, et al. Impact of a national QI programme on reducing electronic health record notifications to clinicians. BMJ Qual Saf. 2018;28(1):10-14. doi:10.1136/bmjqs-2017-007…
  9. Psn-Pdf (pdf file)

    psnet.ahrq.gov/node/38642/psn-pdf
    April 30, 2012 - ASHP national survey of pharmacy practice in hospital settings: dispensing and administration—2008. April 30, 2012 Pedersen CA, Schneider PJ, Scheckelhoff DJ. ASHP national survey of pharmacy practice in hospital settings: dispensing and administration--2008. Am J Health Syst Pharm. 2009;66(10):926-46. doi:10.2146…
  10. Psn-Pdf (pdf file)

    psnet.ahrq.gov/node/46313/psn-pdf
    December 21, 2017 - Patient outcomes in dose reduction or discontinuation of long-term opioid therapy: a systematic review. December 21, 2017 Frank JW, Lovejoy TI, Becker WC, et al. Patient Outcomes in Dose Reduction or Discontinuation of Long- Term Opioid Therapy: A Systematic Review. Ann Intern Med. 2017;167(3):181-191. doi:10.7326/…
  11. Psn-Pdf (pdf file)

    psnet.ahrq.gov/node/45255/psn-pdf
    January 23, 2017 - Provider risk factors for medication administration error alerts: analyses of a large-scale closed-loop medication administration system using RFID and barcode. January 23, 2017 Hwang Y, Yoon D, Ahn EK, et al. Provider risk factors for medication administration error alerts: analyses of a large-scale closed-loop m…
  12. Psn-Pdf (pdf file)

    psnet.ahrq.gov/node/43170/psn-pdf
    December 12, 2014 - Effects of patient-, environment- and medication-related factors on high-alert medication incidents. December 12, 2014 Manias E, Williams A, Liew D, et al. Effects of patient-, environment- and medication-related factors on high-alert medication incidents. Int J Qual Health Care. 2014;26(3):308-20. doi:10.1093/intq…
  13. Psn-Pdf (pdf file)

    psnet.ahrq.gov/node/42298/psn-pdf
    December 31, 2014 - Using statistical text classification to identify health information technology incidents. December 31, 2014 Chai KEK, Anthony S, Coiera E, et al. Using statistical text classification to identify health information technology incidents. J Am Med Inform Assoc. 2013;20(5):980-5. doi:10.1136/amiajnl-2012-001409. htt…
  14. Psn-Pdf (pdf file)

    psnet.ahrq.gov/node/46864/psn-pdf
    August 17, 2018 - Prospective evaluation of medication-related clinical decision support over-rides in the intensive care unit. August 17, 2018 Wong A, Amato MG, Seger DL, et al. Prospective evaluation of medication-related clinical decision support over-rides in the intensive care unit. BMJ Qual Saf. 2018;27(9):718-724. doi:10.1136…
  15. Psn-Pdf (pdf file)

    psnet.ahrq.gov/node/38871/psn-pdf
    August 19, 2009 - Effect of medication reconciliation with and without patient counseling on the number of pharmaceutical interventions among patients discharged from the hospital. August 19, 2009 Karapinar-Carkit F, Borgsteede SD, Zoer J, et al. Effect of medication reconciliation with and without patient counseling on the number…
  16. www.uspreventiveservicestaskforce.org/home/getfilebytoken/ShJmbuCXvmGjpnvyyR9PH_
    Clinical Summary: Screening for Osteoporosis to Prevent Fractures Clinical Summary: Screening for Osteoporosis to Prevent Fractures Population Women 65 years and older Postmenopausal women younger than 65 years at increased risk Men Recommendation Screen for osteoporosis. Grade: B Screen for oste…
  17. www.ahrq.gov/cpi/about/nac/snac-damberg.html
    December 01, 2021 - SNAC Member: Cheryl L. Damberg, Ph.D., M.P.H. RAND Distinguished Chair in Healthcare Payment Policy, Principal Economist RAND Corporation Cheryl L. Damberg, Ph.D., M.P.H., is senior principal researcher and the RAND distinguished chair in health care payment policy. Her research focuses on health system rede…
  18. effectivehealthcare.ahrq.gov/sites/default/files/arthritis-horizon-scan-high-impact-13121.pdf
    December 05, 2013 - Coordinating Council for Comparative Effectiveness Research, AHRQ is interested in innovations in drugs … health care sector, horizon scanning pertains to identification of new (and new uses of existing) pharmaceuticals … For purposes of horizon scanning, AHRQ’s interests are broad and encompass drugs, devices, procedures … Information is compiled for expert comment on topics at a granular level (i.e., similar drugs in the … at Point of This Intervention Patients with OA are often prescribed nonsteroidal anti-inflammatory drugs
  19. effectivehealthcare.ahrq.gov/sites/default/files/ch_6-user-guide-to-ocer_130129.pdf
    October 30, 2012 - Psaty and colleagues have cautioned that because drugs have multiple effects, to the extent that a … www.fda.gov/ Drugs/DevelopmentApprovalProcess/ DrugDevelopmentToolsQualificationProgram/ ucm284077.htm … Surrogate end points and FDA approval: a tale of 2 lipid-altering drugs. … June 2010. www.fda.gov/downloads/Drugs/ GuidanceComplianceRegulatoryInformation/ Guidances/ucm072063.
  20. effectivehealthcare.ahrq.gov/sites/default/files/pdf/cad-women-treatment_research-protocol.pdf
    September 29, 2011 - allergies or adverse effects to individual medications (e.g., aspirin, β-blocker, or cholesterol-lowering drugs … In addition, the definition of optimal medical therapy continues to evolve as new drugs are developed